Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
Cellular and Molecular Gastroenterology and Hepatology - United States
doi 10.1016/j.jcmgh.2018.01.020
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Elsevier BV